The exports by Pakistani pharmaceutical companies grew by 34 percent to $457 million during FY25.
The export figure during FY25 is the highest-ever in Pakistan’s history. The industry recorded exports of $341 million in FY24, $328 million in FY23, and $269 million in FY22.
According to a report by brokerage house Topline Securities, the growth is a result of deregulation of the pricing of non-essential drugs which has helped companies to invest more in new products and exports markets.
The brokerage house expects the exports to grow further during the current fiscal year.